Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AZD5069 |
Synonyms | |
Therapy Description |
AZD5069 binds to and inhibits CXCR2 signaling, resulting in reduced neutrophil chemotaxis (PMID: 25736418, PMID: 29856004). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AZD5069 | AZD-5069|AZD 5069 | CXCR Antagonist 4 | AZD5069 binds to and inhibits CXCR2 signaling, resulting in reduced neutrophil chemotaxis (PMID: 25736418, PMID: 29856004). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|